Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
Blueprint Medicines Corporation
City of Hope Medical Center
Peking University People's Hospital
UNC Lineberger Comprehensive Cancer Center
Nantes University Hospital
University Health Network, Toronto
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Arbeitsgemeinschaft medikamentoese Tumortherapie
Eastern Cooperative Oncology Group
Bristol-Myers Squibb
University of Arkansas
Celgene
Vanderbilt-Ingram Cancer Center
Van Andel Research Institute
University Hospital, Grenoble
Vanderbilt-Ingram Cancer Center
Centre Hospitalier Universitaire de Nice
European Organisation for Research and Treatment of Cancer - EORTC
The Cleveland Clinic
OHSU Knight Cancer Institute
Vanderbilt University Medical Center
Children's Oncology Group
iOMEDICO AG
Vanderbilt University
Columbia University
Mayo Clinic
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center